Brand Name
VIZZ
Generic Name
Aceclidine
View Brand Information FDA approval date: July 31, 2025
Classification: Cholinergic Receptor Agonist
Form: Solution
What is VIZZ (Aceclidine)?
VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults .
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment